Are Peptides coming off of the FDA Category 2 list? A legal breakdown. Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA mulls compounding for peptides previously flagged over safety risks BioSpace